Name | Alagebrium chloride | CAS# | 341028-37-3 | |
---|---|---|---|---|
Price | $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg | Purity | 98.0% | |
Stocking Period |
3 Day | Stock | 3 | |
Product Webpage: | https://www.dcchemicals.com/product_show-Alagebrium_Chloride.html |
Detail
Product Information
Alagebrium Chloride, also known as ALT711, was a drug candidate developed by Alteon, Inc. It was the first drug candidate to be clinically tested for the purpose of breaking the crosslinks caused by advanced glycation endproducts (AGEs), thereby reversing one of the main mechanisms of aging. Through this effect Alagebrium is designed to reverse the stiffening of blood vessel walls that contributes to hypertension and cardiovascular disease, as well as many other forms of degradation associated with protein crosslinking. Alagebrium has proven effective in reducing systolic blood pressure and providing therapeutic benefit for patients with diastolic |
Get all suppliers by the below link:
2024-07-15 |
Alagebrium chloride
Price: Inquiry |
2019-03-05 |
Alagebrium chloride
Price: ¥308.0 |
2022-11-29 |
Alagebrium Chloride
Price: ¥Inquiry |
2021-07-26 |
Alagebrium chloride
Price: $Inquiry |
2024-01-09 |
Alagebrium chloride -
Price: $Inquiry |
2019-04-22 |
ALT-711
Price: $Inquiry |
2023-11-02 |
Alagebrium chloride
Price: ¥Inquiry |
2024-07-19 |
Alagebrium chloride
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved